Investors
Now Fully Financed, Okyanos Is Poised To Start Mending Broken Hearts
Following its $8.9 million Series B capital raise in March, Okyanos Heart Institute is rapidly approaching the day when it will be able to treat the first heart patient using autologous adipose derived regenerative cells (ADRCs) in the Bahamas. Adipose, or fat, is the richest source of regenerative cells in the body and the term "autologous" simply means that the cells are derived from the same patient undergoing the cell therapy treatment.
Australia's Asaleo to raise $617 mln after pricing IPO at middle of range -sources
Toilet paper and tampon maker Asaleo Care Ltd will raise A$656 million ($616.6 million) in Australia's second-largest initial public offering (IPO) of the year after pricing its offer near the middle of an indicative range, two people familiar with the matter said on Tuesday.
Tech moguls raise cash to fight Washington's 'big money problem'
A group of influential Internet moguls aim to fix what they refer to as the "big money problem" in Washington politics by, well, raising cash, forming a Super Political Action Committee (PAC) called Mayday
Private equity buyouts in Asia take old risks with new money
A little over a month ago, a Texas power utility at the centre of the biggest leveraged buyout in history filed for bankruptcy, sunk by billions of dollars of debt that it took on after being acquired by a trio of top private equity names in 2007.